John Crowley Talks About the Fifth Prescription Drug User Fee Act

john-crowley2

On the last day of the World Orphan Drug Congress, John Crowley, Chairman and CEO, Amicus Therapeutics provided an inspiring overview of how the Fifth Prescription Drug User Fee Act (PDUFA V) and new government policies may affect the orphan drug industry. From a historical [...]

“Has the Pendulum Swung Too Far in Favor of Rare Diseases?” Asks Seattle BioPharma Consultant

Stewart Lyman provides strategic advice to clients on their research programs, collaboration management issues and preclinical data reviews.

As a politician, one of the worst things you can be accused of is being a flip-flopper, a person who changes their mind on one or more issues. Another way of looking at this character trait is to say one has thoughtfully wrestled with an issue and changed [...]

FDA Issues Draft to Provide Insight on Benefit-Risk Framework

FDA_Logo

As mandated by the Food and Drug Administration Safety and Innovation Act (FDASIA), the FDA just posted a draft of its “Structured Approach to Benefit-Risk Assessment in Drug Regulatory Decision Making.” There is a 60-day public comment period on the draft, and any individual or [...]

A Reason to Care About Rare: To Increase the Number of More Effective Treatment Options

Orphan_Drugs_Designations

Reposted from The Catalyst. Written by Stephanie Fischer. While 400 therapies for rare diseases are worth celebrating, there is a lot more to learn about rare diseases in order to better diagnose and treat them. Many are inherited and caused by gene mutations, and new rare [...]

The Orphan Drug Act: 30 Years and Still Going Strong!

Orphan_Drug_Act

The Orphan Drug Act (“ODA”), which President Ronald Reagan signed into law on January 4, 1983, turned 30 years old in January, 2013. The milestone came just days after the death of actor Jack Klugman, who has been credited as being an important driving force behind the [...]

Social Security Commissioner to Announce Expansion of Compassionate Allowances List

The Compassionate Allowance List to be announced on Thursday, December 6, 2012.

In their recent Advocacy Alert, the National Organization for Rare Disorders (NORD) encourages patient organization representatives to attend the following announcement: NORD President and CEO Peter L. Saltonstall to Speak at Capitol Hill Event Michael J. Astrue, Commissioner of Social Security, will announce the expansion [...]

We Need Congress to Reach an Agreement to Protect NIH & FDA from Funding Cuts

Please contact your Members of Congress and urge them to protect funding for the Food & Drug Administration & National Institutes of Health!

The election is over, and the status-quo remains. Republicans remain in control of the House of Representatives, while Democrats retain control of the Senate and White House. When Congress returns to work next week for the lame duck session, they must act quickly to protect [...]